Furazolidone
- Generic Name
- Furazolidone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C8H7N3O5
- CAS Number
- 67-45-8
- Unique Ingredient Identifier
- 5J9CPU3RE0
- Background
A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone binds bacterial DNA which leads to the gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
- Indication
For the specific and symptomatic treatment of bacterial or protozoal diarrhea and enteritis caused by susceptible organisms.
- Associated Conditions
- Diarrhea (Dysentery), Infectious diarrhea
- Associated Therapies
- -
Empirical Rescue Therapies of Helicobacter Pylori Infection
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-08-20
- Last Posted Date
- 2013-06-04
- Lead Sponsor
- Shanghai Jiao Tong University School of Medicine
- Target Recruit Count
- 424
- Registration Number
- NCT01668927
- Locations
- 🇨🇳
Renji Hospital, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath